IRIDIAN ASSET MANAGEMENT LLC/CT - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 235 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.

Quarter-by-quarter ownership
IRIDIAN ASSET MANAGEMENT LLC/CT ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,136,356
-54.8%
145,033
-53.6%
2.05%
-1.8%
Q2 2023$22,449,639
+25.2%
312,408
+7.4%
2.09%
+42.2%
Q1 2023$17,934,817
+72882.9%
290,772
-8.7%
1.47%
-37.9%
Q4 2022$24,574
-99.9%
318,611
-20.6%
2.37%
+33.3%
Q3 2022$17,897,000
-13.9%
401,108
-26.1%
1.78%
+4.4%
Q2 2022$20,792,000
-2.9%
542,878
+4.9%
1.70%
+14.1%
Q1 2022$21,423,000
-9.3%
517,580
-17.2%
1.49%
+3.0%
Q4 2021$23,615,000
-50.2%
625,064
-56.6%
1.45%
-0.1%
Q3 2021$47,418,000
-69.9%
1,438,653
-38.5%
1.45%
-47.5%
Q2 2021$157,706,000
+15.4%
2,337,763
-3.2%
2.76%
+18.2%
Q1 2021$136,669,000
-18.7%
2,413,803
+16.9%
2.33%
-23.8%
Q4 2020$168,167,000
+37.0%
2,064,158
+19.8%
3.06%
+14.0%
Q3 2020$122,751,000
+37.4%
1,722,823
+58.7%
2.68%
+36.1%
Q2 2020$89,343,000
+28.5%
1,085,836
-8.2%
1.97%
+17.2%
Q1 2020$69,550,000
+2.9%
1,182,214
+80.7%
1.68%
+51.9%
Q4 2019$67,622,000
+3718.3%
654,239
+647.7%
1.11%
+3857.1%
Q3 2019$1,771,000
-27.3%
87,501
-7.5%
0.03%
-20.0%
Q2 2019$2,436,000
+361.4%
94,601
+154.8%
0.04%
+400.0%
Q1 2019$528,00037,1300.01%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders